You disconnect your cell phone from its charger as you get ready for a busy day. But even though it has been connected all night, the battery is only partially charged. You look at ...

Certain immune cells in MS show abnormalities in activity and signs of reactions against the Epstein-Barr virus, a study says ...

The medication, which will be rolled out to patients with relapsing-remitting MS, is thought to be the first in Europe to be ...

Ocrelizumab significantly reduced the number and volume of cortical lesions associated with multiple sclerosis at 120 weeks, ...

When certified dog trainer Nanette Lai had an MS flare, she figured out workarounds to allow her to still take care of her ...

March is MS Awareness Month, and this week we’re spotlighting the nearly one million people in the U.S. living with multiple sclerosis. Julie Hirsch from the National MS Society of Michigan joins us ...

New research highlights a critical link between antibodies produced against Epstein-Barr virus (EBV) and the development of ...

"It was important to conduct a large randomized controlled trial to evaluate the efficacy of high-dose cholecalciferol as ...

Research reveals how high salt intake disrupts regulatory T cells through specific gene activation, potentially increasing ...

The National Multiple Sclerosis Society says 2.3 million people have been diagnosed with the disease worldwide, but it ...

A detailed review of a 6-month clinical trial further reinforces strong experimental evidence that a ketogenic diet may offer ...

Thousands of NHS patients in England with multiple sclerosis (MS) are set to benefit from a life-changing ‘take at home’ tablet, as the NHS becomes the first healthcare system in Europe to roll it out ...